Advent of bioresorbable stents has brought about paradigm shift in interventional cardiology due to its promising safety and efficacy outcomes. The report “Global Vascular Stents Market (Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents)-Market Outlook 2024” provides information on the current scenario, market outlook of the global vascular stents market with detailed analysis of market segments such as Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global vascular stents market. The report has been segmented as following:-
Market Segments
• Coronary Artery Stents
• Neurovascular Stents
• Peripheral Vascular Stents
Geographical Coverage
• North America - The US
• Europe
• Asia Pacific
Companies Coverage
• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• Microport Scientific Corporation
Vascular stents are tubes inserted into blood vessels anywhere in the body for management of atherosclerosis. These stents are mainly used for cardiovascular stenosis. It leads to significant reduction in occurrence of acute vascular occlusion and restenosis. Vascular stents are classified as coronary artery stents, peripheral stents, and neurovascular stents. Amongst all the aforementioned vascular stents, coronary artery stents is seen to have revolutionized the practice of interventional cardiology. Demand for vascular stents has been rising on an increasing spree due to higher prevalence of diseases affecting heart and blood vessels of elderly and middle-aged population.
Growth of global vascular stents market is primarily attributed to prevalence of vascular diseases, increasing geriatric population, preference for minimally invasive procedure and favorable reimbursement policies. However, some of the factors restraining growth of the industry are stringent regulatory norms, high cost of devices, slow adoption rate and post-operative complications.
The report “Global Vascular Stents Market (Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents)-Market Outlook 2024” provides information on the current scenario, market outlook of the global vascular stents market with detailed analysis of market segments such as Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Future forecasts of vascular stents market overall and across various sub-segments has been provided till 2024, for all the geographies. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global vascular stents market includes Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation and Microport Scientific Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional vascular stents market.
1. Executive Summary
2. Research Methodology
3. Vascular Stents
3.1 Background
3.2 Overview
3.3 Classification
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Products
4.2.2 Market share by Type
4.2.3 Market Share by Region
5. Market Segmentation
5.1 Coronary Stents
5.1.1 Overview
5.1.2 Market Sizing (Actual & Forecasted)
5.1.3 Market Share by Products
5.1.3.1 Bare Metal Stent
5.1.3.2 Bioresorbable Stent
5.1.3.3 Drug Eluting Stent
5.1.4 Market Share by Region
5.2 Neurovascular Stents
5.2.1 Overview
5.2.2 Market Sizing (Actual & Forecasted)
5.3 Peripheral Vascular Stents
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)
5.3.3 Market Share by Products
5.3.3.1 Femoral Artery Stent
5.3.3.2 Infrapop Artery Stent
5.3.3.3 Iliac Artery Stent
5.3.5 Market Share by Region
6. Regional Analysis
6.1 North America
6.1.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.1.2 Market Share by Stent Type
6.1.3 The US
6.1.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.2 Europe
6.2.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.2.2 Market Share by Stent Type
6.3 Asia Pacific
6.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.3.2 Market Share by Products
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Advent of Bioresorbable Vascular Stents
7.1.2 Technological Advancement
7.2 Growth Drivers
7.2.1 Increasing Geriatric Population
7.2.2 Prevalence of Vascular Diseases
7.2.3 Preference for Minimally Invasive Procedures
7.2.4 Favorable Reimbursement Policies
7.3 Challenges
7.3.1 Stringent Regulations
7.3.2 Post-Operative Complications
7.3.3 Slow Adoption Rate
7.3.4 High Cost of Devices
8. Competitive Landscape
8.1 Market Share Analysis
9. Company Profiles
9.1 Abbott Laboratories
9.2 Medtronic PLC
9.3 Boston Scientific Corporation
9.4 Microport Scientific Corporation
List of Tables
Table 1: Types of Coronary Stents and Anti-Restenosis Devices
Table 2: Characteristics of Bioresorbable Vascular Stents
Table 3: Global Vascular Stents Market – Financial Analysis (2018)
Table 4: Global – Status of Applications related to Stents (2018)
Table 5: Global Vascular Stents Market Players – Product Portfolio
Table 6: Global Vascular Stents Market Players – Product Pipeline
List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Coronary Artherosclerosis Diagrammatic Representation
Figure 3: Classification of Stents
Figure 4: Global Vascular Stents Market Size by Value, 2016-24E (US$ Billions)
Figure 5: Global Vascular Stents Market Share by Products (2017)
Figure 6: Global Vascular Stents Market Share by Type of Stent (2017)
Figure 7: Global Coronary Stent Market Share by Region (2017)
Figure 8: Treatment of Coronary Artery Disease
Figure 9: Global Coronary Stents Market Size by Value, 2016-24E (US$ Billions)
Figure 10: Global Coronary Stents Market Share by Products (2017)
Figure 11: Global Coronary Stent – Bare Metal Stent Market Size by Value, 2016-24E (US$ Millions)
Figure 12: Global Coronary Stent – Bioresorbable Stent Market Size by Value, 2016-24E (US$ Millions)
Figure 13: Global Coronary Stent – Drug Eluting Stent Market Size by Value, 2016-24E (US$ Millions)
Figure 14: Global Coronary Stents Market Share by Region (2017)
Figure 15: Global Neurovascular Stents Market Size by Value, 2016-24E (US$ Billions)
Figure 16: Global Peripheral Vascular Stents Market Size by Value, 2016-24E (US$ Billions)
Figure 17: Global Peripheral Vascular Stents Market Share by Product (2017)
Figure 18: Global Peripheral Vascular – Femoral Artery Stents Market Size by Value, 2016-24E (US$ Millions)
Figure 19: Global Peripheral Vascular – Infrapop Artery Stents Market Size by Value, 2016-24E (US$ Millions)
Figure 20: Global Peripheral Vascular – Iliac Artery Stents Market Size by Value, 2016-24E (US$ Millions)
Figure 21: Global Peripheral Vascular Stents Market Share by Region (2017)
Figure 22: North America Vascular Stents Market Size by Value, 2016-24E (US$ Millions)
Figure 23: North America Vascular Stents Market Share by Type of Stent (2017)
Figure 24: The US Vascular Stents Market Size by Value, 2016-24E (US$ Millions)
Figure 25: Europe Vascular Stents Market Size by Value, 2016-24E (US$ Millions)
Figure 26: Europe Vascular Stents Market Share by Type of Stent (2017)
Figure 27: Asia Pacific Vascular Stents Market Size by Value, 2016-24E (US$ Millions)
Figure 28: Asia Pacific Vascular Stents Market Share by Type of Stent (2017)
Figure 29: Global Ageing (60 Years and above) Population, 2012-18E (Millions)
Figure 30: Global Vascular Disease Incidences, 2012-18E (Millions)
Figure 31: Global Drug Eluting Stent (DES) Market Share by Competitors (2017)
Figure 32: Abbott Laboratories Revenue by Business Segment (FY2017)
Figure 33: Abbott Laboratories Net Sales, FY2013-FY2017 (US$ Billions)
Figure 34: Medtronic PLC Revenue by Business Segment (FY2017)
Figure 35: Medtronic PLC Net Sales, FY2013-FY2017 (US$ Billions)
Figure 36: Boston Scientific Corporation Revenue by Business Segment (FY2017)
Figure 37: Boston Scientific Corporation Net Sales, FY2013-FY2017 (US$ Billions)
Figure 38: Microport Scientific Corporation Revenue by Business Segment (FY2017)
Figure 39: Microport Scientific Corporation Net Sales, FY2013-FY2017 (US$ Billions)
Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation and Microport Scientific Corporation
*If Applicable.